These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Lecithin microemulsions in dimethyl ether and propane for the generation of pharmaceutical aerosols containing polar solutes. Sommerville ML; Johnson CS; Cain JB; Rypacek F; Hickey AJ Pharm Dev Technol; 2002; 7(3):273-88. PubMed ID: 12229259 [TBL] [Abstract][Full Text] [Related]
3. Lecithin inverse microemulsions for the pulmonary delivery of polar compounds utilizing dimethylether and propane as propellants. Sommerville ML; Cain JB; Johnson CS; Hickey AJ Pharm Dev Technol; 2000; 5(2):219-30. PubMed ID: 10810752 [TBL] [Abstract][Full Text] [Related]
4. Aerodynamic particle size analysis of aerosols from pressurized metered-dose inhalers: comparison of Andersen 8-stage cascade impactor, next generation pharmaceutical impactor, and model 3321 Aerodynamic Particle Sizer aerosol spectrometer. Mitchell JP; Nagel MW; Wiersema KJ; Doyle CC AAPS PharmSciTech; 2003 Oct; 4(4):E54. PubMed ID: 15198549 [TBL] [Abstract][Full Text] [Related]
5. A correlation equation for the mass median aerodynamic diameter of the aerosol emitted by solution metered dose inhalers. Ivey JW; Lewis D; Church T; Finlay WH; Vehring R Int J Pharm; 2014 Apr; 465(1-2):18-24. PubMed ID: 24524827 [TBL] [Abstract][Full Text] [Related]
6. New analytical techniques to facilitate preformulation screening in propellant systems. Mogalian E; Kuehl PJ; Myrdal PB Int J Pharm; 2007 Aug; 340(1-2):223-9. PubMed ID: 17498897 [TBL] [Abstract][Full Text] [Related]
7. Particle size study of nine metered dose inhalers, and their deposition probabilities in the airways. Bouchikhi A; Becquemin MH; Bignon J; Roy M; Teillac A Eur Respir J; 1988 Jun; 1(6):547-52. PubMed ID: 3169224 [TBL] [Abstract][Full Text] [Related]
8. Reverse aqueous microemulsions in hydrofluoroalkane propellants and their aerosol characteristics. Selvam P; Bharatwaj B; Porcar L; da Rocha SR Int J Pharm; 2012 Jan; 422(1-2):428-35. PubMed ID: 22044539 [TBL] [Abstract][Full Text] [Related]
9. Investigation of some commercially available spacer devices for the delivery of glucocorticoid steroids from a pMDI. Williams RO; Patel AM; Barron MK; Rogers TL Drug Dev Ind Pharm; 2001 May; 27(5):401-12. PubMed ID: 11448047 [TBL] [Abstract][Full Text] [Related]
10. Size aspects of metered-dose inhaler aerosols. Kim CS; Trujillo D; Sackner MA Am Rev Respir Dis; 1985 Jul; 132(1):137-42. PubMed ID: 4014858 [TBL] [Abstract][Full Text] [Related]
11. Propellant-driven aerosols for delivery of proteins in the respiratory tract. Brown AR; Pickrell JA J Aerosol Med; 1995; 8(1):43-58. PubMed ID: 10151081 [TBL] [Abstract][Full Text] [Related]
12. The influence of formulation and spacer device on the in vitro performance of solution chlorofluorocarbon-free propellant-driven metered dose inhalers. Smyth HD; Beck VP; Williams D; Hickey AJ AAPS PharmSciTech; 2004 Feb; 5(1):E7. PubMed ID: 15198528 [TBL] [Abstract][Full Text] [Related]
13. Effect of energy on propylene glycol aerosols using the capillary aerosol generator. Shen X; Hindle M; Byron PR Int J Pharm; 2004 May; 275(1-2):249-58. PubMed ID: 15081155 [TBL] [Abstract][Full Text] [Related]
14. Formulation and evaluation of novel reverse microemulsions containing salmon calcitonin in hydrofluoroalkane propellants. Shan Z; Tan Y; Qin L; Li G; Pan X; Wang Z; Yu X; Wang Q; Wu C Int J Pharm; 2014 May; 466(1-2):390-9. PubMed ID: 24657140 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of a new Aerodynamic Particle Sizer Spectrometer for size distribution measurements of solution metered dose inhalers. Stein SW; Myrdal PB; Gabrio BJ; Obereit D; Beck TJ J Aerosol Med; 2003; 16(2):107-19. PubMed ID: 12823905 [TBL] [Abstract][Full Text] [Related]
16. Inhalation delivery of anticancer agents via HFA-based metered dose inhaler using methotrexate as a model drug. Shaik MS; Haynes A; McSween J; Ikediobi O; Kanikkannan N; Singh M J Aerosol Med; 2002; 15(3):261-70. PubMed ID: 12396414 [TBL] [Abstract][Full Text] [Related]
17. In-vitro and in-vivo respiratory deposition of a developed metered dose inhaler formulation of an anti-migraine drug. Abdou EM; Kandil SM; Morsi A; Sleem MW Drug Deliv; 2019 Dec; 26(1):689-699. PubMed ID: 31274014 [TBL] [Abstract][Full Text] [Related]
18. In vitro characterization of nebulizer delivery of liposomal amphotericin B aerosols. Alexander BD; Winkler TP; Shi S; Dodds Ashley ES; Hickey AJ Pharm Dev Technol; 2011; 16(6):577-82. PubMed ID: 21699390 [TBL] [Abstract][Full Text] [Related]
19. Crosslinked chitosan nanoparticle formulations for delivery from pressurized metered dose inhalers. Sharma K; Somavarapu S; Colombani A; Govind N; Taylor KM Eur J Pharm Biopharm; 2012 May; 81(1):74-81. PubMed ID: 22245573 [TBL] [Abstract][Full Text] [Related]
20. Influence of propellant composition on drug delivery from a pressurized metered-dose inhaler. Williams RO; Repka M; Liu J Drug Dev Ind Pharm; 1998 Aug; 24(8):763-70. PubMed ID: 9876524 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]